Christopher Scott

Christopher Scott is an accomplished finance professional with extensive experience in accounting and management. Currently serving as Executive Director and Treasurer at Ultragenyx Pharmaceutical Inc. since May 2015, Christopher has held several key positions including Senior Director and Director of Accounting Operations. Previously, Christopher worked as Director of Accounting at InterMune, which was acquired by Roche, and held the Associate Director title at Onyx Pharmaceuticals before its acquisition by Amgen. Christopher’s career also includes roles at Amyris, Bristol-Myers Squibb, EisnerAmper, and Medco Health Solutions. Educational qualifications include an Executive Certification from MIT Sloan School of Management, an MBA from Rutgers Business School, and a B.S. in Business Administration with a focus on Accounting from the University of Rhode Island.